PD+ Health: How do SMEs and MNCs approach transactions?

PD+ Health: How do SMEs and MNCs approach transactions?

Selling or licensing your IP or drug development work to a pharmaceutical company is one way of progressing a promising new drug candidate.

By Campus+

Date and time

Thu, 9 Nov 2023 5:00 PM - 6:00 PM PST

Location

Online

About this event

This webinar aims to give you the perspective from the other side of the table so you can be better prepared when entering into negotiations with Pharma.

  • Current state of play in Pharma transactions – an overview
  • Understanding Pharma motivators
  • Types and stage of deals
  • The role of the deal champion
  • Finding the win-win outcome
  • The integration process – beyond the deal

Meet your presenter: Rob Crombie

Rob Crombie is currently the VIC/TAS State Lead for i4 Connect delivering the Federal Governments Accelerating Commercialisation programme through his role as Managing Director of Concept2Clinic Consulting, a specialist professional services company looking to turn smart innovation into commercial ventures. Rob’s has had previous roles as CEO of VC backed QUE Oncology Incorporated as well as the founding CEO of ASX-listed Prescient Therapeutics, in-licensing early stage drug candidates from Universities including Yale and Emory University and building value by advancing these assets through company sponsored clinical trials.

Organised by

Sales Ended